Cargando…
Nafamostat mesylate prevents metastasis and dissemination of neuroblastoma through vascular endothelial growth factor inhibition
Neuroblastoma is a highly malignant disease with a poor prognosis and few treatment options. Despite conventional chemotherapy for neuroblastoma, resistance, invasiveness, and metastatic mobility limit the treatment efficacy. Therefore, it is necessary to develop new strategies for treating neurobla...
Autores principales: | Morimoto, Mari, Toyoda, Hidemi, Niwa, Kaori, Hanaki, Ryo, Okuda, Taro, Nakato, Daisuke, Amano, Keishiro, Iwamoto, Shotaro, Hirayama, Masahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353881/ https://www.ncbi.nlm.nih.gov/pubmed/35949892 http://dx.doi.org/10.3892/mco.2022.2571 |
Ejemplares similares
-
Donor‐derived M2 macrophages attenuate GVHD after allogeneic hematopoietic stem cell transplantation
por: Hanaki, Ryo, et al.
Publicado: (2021) -
Improved Antitumor Effect of NK Cells Activated by Neutrophils in a Bone Marrow Transplant Model
por: Nakato, Daisuke, et al.
Publicado: (2023) -
CD3+ B-1a Cells as a Mediator of Disease Progression in Autoimmune-Prone Mice
por: Yamamoto, Wakako, et al.
Publicado: (2018) -
Successful hematopoietic stem cell transplantation for two patients with relapse of intrachromosomal amplification of chromosome 21-positive B-cell precursor acute lymphoblastic leukemia
por: Harada, Tomoya, et al.
Publicado: (2022) -
Nafamostat mesylate attenuates the pathophysiologic sequelae of neurovascular ischemia
por: Ghali, George Zaki, et al.
Publicado: (2020)